BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
China's GLP-1 landscape
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
PFA re-energizes afib market
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, October 18, 2024
Home
»
Authors
»
Nuala Moran
Articles by Nuala Moran
Xenova On Track To Partner XR9576 Following Phase II
Feb. 28, 2001
By
Nuala Moran
No Comments
MVM Raising £40M To Invest In Young U.S., UK Companies
Feb. 28, 2001
By
Nuala Moran
No Comments
Xenova, Cantab Merging Via All-Stock Deal Valued At £124
Feb. 21, 2001
By
Nuala Moran
No Comments
Cyclacel Moves Oral CDK Inhibitor Into Human Trials
Feb. 21, 2001
By
Nuala Moran
No Comments
Pharming Completes Study, Enters Deal With AM-Pharma
Feb. 21, 2001
By
Nuala Moran
No Comments
Cyclacel Moves Oral CDK Inhibitor Into Human Trials
Feb. 21, 2001
By
Nuala Moran
No Comments
Xenova, Cantab Merging Via All-Stock Deal Valued At £124
Feb. 21, 2001
By
Nuala Moran
No Comments
Pharming Completes Study, Enters Deal With AM-Pharma
Feb. 21, 2001
By
Nuala Moran
No Comments
HUPO Formed To Capitalize On Genome, Advance Proteomics
Feb. 20, 2001
By
Nuala Moran
No Comments
HUPO Formed To Capitalize On Genome, Advance Proteomics
Feb. 20, 2001
By
Nuala Moran
No Comments
Previous
1
2
…
488
489
490
491
492
493
494
495
496
497
Next